Rapport Therapeutics, Inc. RAPP Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s change in AP?
- Rapport Therapeutics, Inc. (RAPP) reported change in AP of $2.31M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s change in AP changed year-over-year?
- Rapport Therapeutics, Inc.'s change in AP increased by 1145.9% year-over-year, from $185K to $2.31M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.